NO20023367L - Glyburide-preparat - Google Patents

Glyburide-preparat

Info

Publication number: NO20023367L
Authority: NO; Norway
Prior art keywords: glyburide; preparation; glyburide preparation
Prior art date: 2000-01-14

Application number

NO20023367A

Other languages

English (en)

Other versions

NO328152B1 (no

NO20023367D0 (no

Inventor

Gillian Cave

Sarah J Nicholson

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-14

Filing date

2002-07-12

Publication date

2002-09-04

2002-07-12 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2002-07-12 Publication of NO20023367D0 publication Critical patent/NO20023367D0/no

2002-09-04 Publication of NO20023367L publication Critical patent/NO20023367L/no

2009-12-21 Publication of NO328152B1 publication Critical patent/NO328152B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/59—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of rings other than six-membered aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cephalosporin Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)

NO20023367A 2000-01-14 2002-07-12 Glyburid og glyburid-preparater samt anvendelse av disse for fremstilling av medikament for behandling av sykdom NO328152B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US48370300A	2000-01-14	2000-01-14
PCT/US2001/000234 WO2001051463A1 (en)	2000-01-14	2001-01-04	Glyburide composition

Publications (3)

Publication Number	Publication Date
NO20023367D0 NO20023367D0 (no)	2002-07-12
NO20023367L true NO20023367L (no)	2002-09-04
NO328152B1 NO328152B1 (no)	2009-12-21

Family

ID=23921174

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023367A NO328152B1 (no)	2000-01-14	2002-07-12	Glyburid og glyburid-preparater samt anvendelse av disse for fremstilling av medikament for behandling av sykdom

Country Status (37)

Country	Link
US (2)	US20010036479A1 (no)
EP (1)	EP1250321B1 (no)
JP (1)	JP4787446B2 (no)
KR (1)	KR100739906B1 (no)
CN (1)	CN1210258C (no)
AR (1)	AR031547A1 (no)
AT (1)	ATE330937T1 (no)
AU (1)	AU771705B2 (no)
BG (1)	BG65782B1 (no)
BR (1)	BR0107564A (no)
CA (1)	CA2397294C (no)
CY (1)	CY1106328T1 (no)
CZ (1)	CZ20022429A3 (no)
DE (1)	DE60120916T2 (no)
DK (1)	DK1250321T3 (no)
EE (1)	EE05020B1 (no)
ES (1)	ES2264967T3 (no)
GE (1)	GEP20043299B (no)
HU (1)	HU228825B1 (no)
IL (2)	IL150383A0 (no)
LT (1)	LT5024B (no)
LV (1)	LV12914B (no)
MX (1)	MXPA02006835A (no)
MY (1)	MY128577A (no)
NO (1)	NO328152B1 (no)
NZ (1)	NZ519920A (no)
PT (1)	PT1250321E (no)
RO (1)	RO121381B1 (no)
RU (1)	RU2244707C2 (no)
SK (1)	SK286925B6 (no)
TN (1)	TNSN01005A1 (no)
TR (1)	TR200201798T2 (no)
TW (1)	TWI287989B (no)
UA (1)	UA73968C2 (no)
UY (1)	UY26529A1 (no)
WO (1)	WO2001051463A1 (no)
ZA (1)	ZA200205528B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7767249B2 (en) *	2001-06-07	2010-08-03	Hewlett-Packard Development Company, L.P.	Preparation of nanoparticles
US20050271737A1 (en) *	2001-06-07	2005-12-08	Chinea Vanessa I	Application of a bioactive agent to a substrate
US20050131027A1 (en) *	2002-03-21	2005-06-16	Guy Samburski	Fine particle size pioglitazone
US8911781B2 (en)	2002-06-17	2014-12-16	Inventia Healthcare Private Limited	Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
PL1677792T3 (pl)	2003-10-31	2016-05-31	Takeda Pharmaceuticals Co	Stały preparat zawierający pioglitazon, glimepiryd i ester polioksyetylenosorbitanu z kwasem tłuszczowym
RU2359677C2 (ru) *	2004-04-29	2009-06-27	Лотус Фармасьютикал Ко., Лтд	Оральные таблетки с модифицированным высвобождением и способ их получения
CN100455279C (zh) *	2004-04-29	2009-01-28	美时化学制药股份有限公司	口服延迟释放锭剂组成物及其制法
WO2005105109A1 (en) *	2004-04-29	2005-11-10	Lotus Pharmaceutical Co., Ltd.	Oral modified-release lozenges and their preparation method
CN100341495C (zh) *	2004-12-29	2007-10-10	三九医药股份有限公司	格列本脲固体分散体、口服组合物及其制备方法
WO2006109175A2 (en) *	2005-04-11	2006-10-19	Aurobindo Pharma Limited	Solid dosage form of an antidiabetic drug
US8529537B2 (en) *	2005-08-05	2013-09-10	Kimberly-Clark Worldwide, Inc.	Absorbent article with enclosures
NZ565955A (en)	2005-08-22	2011-08-26	Melior Pharmaceuticals I Inc	Methods and formulations for modulating lyn kinase activity and treating related disorders
CN101287467B (zh) *	2005-08-22	2011-01-19	梅里奥尔医药I公司	用于调节Lyn激酶活性和治疗相关病症的方法和制剂
JP2009537478A (ja) *	2006-05-13	2009-10-29	ノヴォノルディスクアクティーゼルスカブ	レパグリニドとメトホルミンを含む錠剤配合物
WO2008026668A1 (en) *	2006-08-31	2008-03-06	Daiichi Sankyo Company, Limited	Medicinal composition containing insulin resistance improving agent
EP1967182A1 (en) *	2007-03-07	2008-09-10	KRKA, tovarna zdravil, d.d., Novo mesto	Pharmaceutical composition comprising a salt of rosigliatazone
US8552184B2 (en)	2008-07-03	2013-10-08	Melior Pharmaceuticals I, Inc.	Compounds and methods for treating disorders related to glucose metabolism
WO2010048287A2 (en)	2008-10-22	2010-04-29	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Radioprotective agents
FI2395968T3 (fi)	2009-02-13	2024-02-27	Boehringer Ingelheim Int	Glukopyranosylidifenylimetaanijohdannaisia sisältävä farmaseuttinen koostumus, niiden farmaseuttinen annostusmuoto, niiden valmistusmenetelmä ja niiden käyttö potilaan glukemiasäädön parantamiseksi
US20130158055A1 (en)	2010-05-28	2013-06-20	Andrew G. Reaume	Prevention Of Pancreatic Beta Cell Degeneration
EP2520298A1 (en)	2011-05-03	2012-11-07	Assistance Publique, Hopitaux De Paris	Pharmaceutical composition comprising sulfonylureas (glibenclamide) or meglitinides for use for treating hyperglycaemia or for promoting growth of a premature infant
CN102743354A (zh) *	2012-07-31	2012-10-24	南京正科制药有限公司	瑞格列奈片及其制备方法
CN103142521B (zh) *	2013-03-21	2014-06-25	西南药业股份有限公司	格列本脲片及其制备方法
CN104127424A (zh) *	2014-07-30	2014-11-05	沈阳药科大学	格列本脲衍生物及其制备方法和应用
CN104127423A (zh) *	2014-07-30	2014-11-05	沈阳药科大学	格列喹酮衍生物及其制备方法和应用
KR102634575B1 (ko)	2017-04-10	2024-02-06	멜리어 파마슈티칼스 아이, 인코포레이티드	지방세포의 처리
CN113143940A (zh) *	2020-12-30	2021-07-23	成都恒瑞制药有限公司	一种抗糖尿病药物组合物的制备方法
WO2023012610A1 (en) *	2021-08-03	2023-02-09	Avaca Pharma Private Limited	Formulations, compositions and methods for the treatment of stroke

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3174901A (en) *	1963-01-31	1965-03-23	Jan Marcel Didier Aron Samuel	Process for the oral treatment of diabetes
DE1185180B (de)	1963-10-19	1965-01-14	Hoechst Ag	Verfahren zur Herstellung von Benzolsulfonylharnstoffen
US3454635A (en)	1965-07-27	1969-07-08	Hoechst Ag	Benzenesulfonyl-ureas and process for their manufacture
CA889876A (en)	1970-09-10	1972-01-04	Frank W. Horner Limited	Purification of glyburide
US4060634A (en) *	1973-09-26	1977-11-29	Boehringer Mannheim G.M.B.H.	Rapidly resorbable glibenclamide
DE2348334C2 (de) *	1973-09-26	1982-11-11	Boehringer Mannheim Gmbh, 6800 Mannheim	Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
US4916163A (en) *	1985-06-04	1990-04-10	The Upjohn Company	Spray-dried lactose formulation of micronized glyburide
DE3833439A1 (de)	1988-10-01	1991-09-12	Hoechst Ag	Verfahren zur mikronisierung von glibenclamid
RU2026670C1 (ru)	1988-10-05	1995-01-20	Дзе Апджон Компани	Способ получения тонкодисперсного твердого фармацевтического вещества
US5258185A (en) *	1989-08-23	1993-11-02	Bauer Kurt H	Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
EP0615445B1 (de) *	1991-12-05	1996-05-15	ALFATEC-PHARMA GmbH	Pharmazeutisch applizierbares nanosol und verfahren zu seiner herstellung
DK36392D0 (da) *	1992-03-19	1992-03-19	Novo Nordisk As	Anvendelse af kemisk forbindelse
DE4323636A1 (de) *	1993-07-15	1995-01-19	Hoechst Ag	Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
TWI238064B (en) *	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) *	1995-11-14	1997-10-27	Gentili Ist Spa	Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
US6153632A (en) *	1997-02-24	2000-11-28	Rieveley; Robert B.	Method and composition for the treatment of diabetes
DE19721467A1 (de) *	1997-05-22	1998-11-26	Basf Ag	Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
AP1279A (en)	1997-06-18	2004-05-20	Smithkline Beecham Plc	Treatment of diabetes with thiazolidinedione and metformin.
GB9715306D0 (en)	1997-07-18	1997-09-24	Smithkline Beecham Plc	Novel method of treatment
DE69811233T2 (de) *	1997-10-27	2003-11-20	Merck Patent Gmbh	Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
DK0974356T3 (da)	1998-07-15	2003-10-27	Merck Sante Sas	Tabletter omfattende en kombination af metformin og glibenclamid
US7374779B2 (en) *	1999-02-26	2008-05-20	Lipocine, Inc.	Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) *	1999-02-26	2001-09-25	Lipocine, Inc.	Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents

2000
- 2000-12-11 US US09/735,334 patent/US20010036479A1/en not_active Abandoned
- 2000-12-20 MY MYPI20005969A patent/MY128577A/en unknown
2001
- 2001-01-04 CN CNB018036392A patent/CN1210258C/zh not_active Expired - Lifetime
- 2001-01-04 PT PT01900328T patent/PT1250321E/pt unknown
- 2001-01-04 EE EEP200200393A patent/EE05020B1/xx unknown
- 2001-01-04 DK DK01900328T patent/DK1250321T3/da active
- 2001-01-04 TR TR2002/01798T patent/TR200201798T2/xx unknown
- 2001-01-04 MX MXPA02006835A patent/MXPA02006835A/es active IP Right Grant
- 2001-01-04 EP EP01900328A patent/EP1250321B1/en not_active Expired - Lifetime
- 2001-01-04 BR BR0107564-0A patent/BR0107564A/pt not_active Application Discontinuation
- 2001-01-04 HU HU0203852A patent/HU228825B1/hu unknown
- 2001-01-04 GE GE4874A patent/GEP20043299B/en unknown
- 2001-01-04 RO ROA200200979A patent/RO121381B1/ro unknown
- 2001-01-04 ES ES01900328T patent/ES2264967T3/es not_active Expired - Lifetime
- 2001-01-04 CA CA2397294A patent/CA2397294C/en not_active Expired - Lifetime
- 2001-01-04 JP JP2001551845A patent/JP4787446B2/ja not_active Expired - Lifetime
- 2001-01-04 IL IL15038301A patent/IL150383A0/xx active IP Right Grant
- 2001-01-04 WO PCT/US2001/000234 patent/WO2001051463A1/en not_active Ceased
- 2001-01-04 AT AT01900328T patent/ATE330937T1/de active
- 2001-01-04 KR KR1020027009084A patent/KR100739906B1/ko not_active Expired - Lifetime
- 2001-01-04 DE DE60120916T patent/DE60120916T2/de not_active Expired - Lifetime
- 2001-01-04 CZ CZ20022429A patent/CZ20022429A3/cs unknown
- 2001-01-04 NZ NZ519920A patent/NZ519920A/en not_active IP Right Cessation
- 2001-01-04 AU AU24740/01A patent/AU771705B2/en not_active Expired
- 2001-01-04 RU RU2002121626/04A patent/RU2244707C2/ru active
- 2001-01-04 SK SK983-2002A patent/SK286925B6/sk not_active IP Right Cessation
- 2001-01-08 TW TW090100369A patent/TWI287989B/zh not_active IP Right Cessation
- 2001-01-11 TN TNTNSN01005A patent/TNSN01005A1/en unknown
- 2001-01-11 UY UY26529A patent/UY26529A1/es not_active Application Discontinuation
- 2001-01-12 AR ARP010100161A patent/AR031547A1/es not_active Application Discontinuation
- 2001-04-01 UA UA2002086718A patent/UA73968C2/uk unknown
2002
- 2002-06-24 BG BG106870A patent/BG65782B1/bg unknown
- 2002-06-24 IL IL150383A patent/IL150383A/en unknown
- 2002-07-10 ZA ZA200205528A patent/ZA200205528B/xx unknown
- 2002-07-12 NO NO20023367A patent/NO328152B1/no not_active IP Right Cessation
- 2002-07-23 LT LT2002085A patent/LT5024B/lt not_active IP Right Cessation
- 2002-08-09 LV LVP-02-144A patent/LV12914B/en unknown
2003
- 2003-04-30 US US10/426,211 patent/US6830760B2/en not_active Expired - Lifetime
2006
- 2006-09-20 CY CY20061101349T patent/CY1106328T1/el unknown

Also Published As

Publication number	Publication date
BG106870A (en)	2003-03-31
EE05020B1 (et)	2008-06-16
BG65782B1 (bg)	2009-11-30
MY128577A (en)	2007-02-28
GEP20043299B (en)	2004-03-10
RO121381B1 (ro)	2007-04-30
SK9832002A3 (en)	2003-07-01
JP4787446B2 (ja)	2011-10-05
CN1395560A (zh)	2003-02-05
EE200200393A (et)	2003-10-15
BR0107564A (pt)	2002-10-01
HU228825B1 (en)	2013-05-28
NO328152B1 (no)	2009-12-21
NO20023367D0 (no)	2002-07-12
HUP0203852A3 (en)	2005-05-30
JP2003519681A (ja)	2003-06-24
DE60120916T2 (de)	2007-02-15
CZ20022429A3 (cs)	2003-06-18
UY26529A1 (es)	2001-08-27
NZ519920A (en)	2004-06-25
TWI287989B (en)	2007-10-11
PL356210A1 (en)	2004-06-14
US20010036479A1 (en)	2001-11-01
UA73968C2 (en)	2005-10-17
US6830760B2 (en)	2004-12-14
EP1250321B1 (en)	2006-06-21
CA2397294C (en)	2011-03-22
CN1210258C (zh)	2005-07-13
ATE330937T1 (de)	2006-07-15
LV12914B (en)	2003-01-20
SK286925B6 (sk)	2009-07-06
LT2002085A (en)	2003-01-27
ZA200205528B (en)	2003-10-10
AR031547A1 (es)	2003-09-24
US20030185880A1 (en)	2003-10-02
CA2397294A1 (en)	2001-07-19
IL150383A0 (en)	2002-12-01
EP1250321A1 (en)	2002-10-23
DE60120916D1 (de)	2006-08-03
RU2244707C2 (ru)	2005-01-20
PT1250321E (pt)	2006-09-29
CY1106328T1 (el)	2011-10-12
IL150383A (en)	2007-03-08
RU2002121626A (ru)	2004-01-10
DK1250321T3 (da)	2006-07-31
TNSN01005A1 (en)	2005-11-10
TR200201798T2 (tr)	2002-11-21
LT5024B (lt)	2003-06-25
KR20020073169A (ko)	2002-09-19
WO2001051463A1 (en)	2001-07-19
ES2264967T3 (es)	2007-02-01
HUP0203852A2 (hu)	2003-04-28
AU771705B2 (en)	2004-04-01
KR100739906B1 (ko)	2007-07-16
MXPA02006835A (es)	2003-01-28
AU2474001A (en)	2001-07-24

Publication	Publication Date	Title
NO20023367L (no)	2002-09-04	Glyburide-preparat
DK1857105T3 (da)	2010-09-20	Kathartisk præparat
EP1329217A4 (en)	2007-04-04	Solid preparations
DE60126142D1 (de)	2007-03-08	Bioabsorbierbare wundauflage
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
NO20032514D0 (no)	2003-06-03	Polypropylenharpikssammensetninger
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
DE60133295D1 (de)	2008-04-30	Sulphoniumsalz-verbindung
DE60128599D1 (de)	2007-07-05	Arbeitsgerät
EE200200526A (et)	2004-04-15	Kapslid
ATA2932001A (de)	2004-11-15	Schneefräse
DE50114386D1 (de)	2008-11-20	Ng
DE60143985D1 (de)	2011-03-17	Os
DE60107598D1 (de)	2005-01-05	Smart-skin strukturen
EE200200150A (et)	2003-04-15	Preparaat
EE200200525A (et)	2004-04-15	Kapslid
NO20013129L (no)	2001-12-24	Brönnpakning
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
ATE298751T1 (de)	2005-07-15	7-oxopyridoryrimidine
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
NO20031034L (no)	2003-03-06	Kromanonderivater
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
DE10052925B4 (de)	2005-03-10	Schaukelbett
DE10085445T1 (de)	2003-02-27	Drahterodierbearbeitungseinrichtung

Legal Events

Date	Code	Title	Description
2021-01-11	MK1K	Patent expired